Skip to main content
  • TRILUMINATE Trial Details Qualify-of-Life Improvements in Severe TR Treated with TriClip vs. Medical Therapy

    A deeper look into the TRILUMINATE pivotal trial results shows that transcatheter edge-to-edge repair (TEER) for patients with symptomatic, severe tricuspid regurgitation resulted in meaningfully improved quality of life in patients with mostly concomitant, but treated, left-sided valve disease.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details